Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain-containing protein 7B (ZBTB7B, also known as ThPOK) is a transcription factor characterized by zinc finger domains and a BTB/POZ domain. It acts chiefly as a master regulator of T-cell fate, directing the commitment of immature thymocytes to the CD4⁺ helper lineage by repressing CD8 expression and silencing critical genes via epigenetic mechanisms. ZBTB7B is required for normal development of multiple immune lineages, including γδT and NKT cells, and plays roles beyond the immune system in regulating metabolism, mammary gland function, and adipose tissue differentiation. Dysregulation or mutation of ZBTB7B is implicated in certain cancers and rare diseases and serves as a molecular switch in immune cell differentiation and function.
Drugs or interventions (if developed) would likely act as inhibitors or modulators of transcription factor activity, DNA-binding, epigenetic recruitment (e.g., histone deacetylase interactions), or protein-protein interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 7B (ZBTB7B).